Drugmakers’ leading industry group is the latest to file a lawsuit seeking to stop Medicare’s newly granted power to negotiate drug prices. The Pharmaceutical Research and Manufacturers of America, known as PhRMA, argues that the negotiation provision is unconstitutional.
CNN.com – RSS Channel Drugmakers’ leading industry group is the latest to file a lawsuit seeking to stop Medicare’s newly granted power to negotiate drug prices. The Pharmaceutical Research and Manufacturers of America, known as PhRMA, argues that the negotiation provision is unconstitutional.
Read More Drugmakers’ leading industry group is the latest to file a lawsuit seeking to stop Medicare’s newly granted power to negotiate drug prices. The Pharmaceutical Research and Manufacturers of America, known as PhRMA, argues that the negotiation provision is unconstitutional.